Viking Therapeutics (VKTX) Q4 2024 Earnings

23OctConfirmed
Q4 2023
Q1 2024
Q3 2024
Q4 2024
-0.28
-0.25
-0.23
-0.2

Details

Expected EPS
-0.242875
Actual EPS
-0.22
Surprise EPS
0.02
Surprise Percent
+9.42%

Description

Viking Therapeutics (VKTX) has reported earnings of -0.22 per share for Q4 2024.

0 Comments

Share your thoughts